TN HB0913 | 2023-2024 | 113th General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 30 2023 - 25% progression
Action: 2023-03-07 - Taken off notice for cal in s/c Health Subcommittee of Health Committee
Text: Latest bill text (Draft #3) [PDF]
Status: Introduced on January 30 2023 - 25% progression
Action: 2023-03-07 - Taken off notice for cal in s/c Health Subcommittee of Health Committee
Text: Latest bill text (Draft #3) [PDF]
Summary
As introduced, requires a practitioner to discuss with patients the addiction and overdose risks associated with certain prescription drugs, alternative treatments that may be available, and the reasons why the prescription is necessary prior to issuing an initial prescription and prior to issuing a third prescription for certain controlled substances in a course of treatment for acute or chronic pain. - Amends TCA Title 39; Title 53 and Title 63.
Title
AN ACT to amend Tennessee Code Annotated, Title 39; Title 53 and Title 63, relative to prescription drugs.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-03-07 | House | Taken off notice for cal in s/c Health Subcommittee of Health Committee |
| 2023-03-01 | House | Placed on s/c cal Health Subcommittee for 3/7/2023 |
| 2023-02-07 | House | Assigned to s/c Health Subcommittee |
| 2023-02-02 | House | P2C, ref. to Health Committee |
| 2023-02-01 | House | Sponsor(s) withdrawn. |
| 2023-02-01 | House | Sponsor change. |
| 2023-02-01 | House | Intro., P1C. |
| 2023-01-30 | House | Filed for introduction |
Same As/Similar To
SB1168 (Crossfiled) 2023-02-06 - Passed on Second Consideration, refer to Senate Judiciary Committee
